CORDIS
EU research results

CORDIS

English EN
System for AcceleroMeter-Based Assessment of cardiac FUNction

System for AcceleroMeter-Based Assessment of cardiac FUNction

Objective

In patients undergoing open-heart surgeries, perioperative cardiac monitoring is used to track the functioning of the heart and identify complications. However, myocardial failure and other severe complications can escape detection using current monitoring technologies, given the trade-offs between invasiveness, real time measurements, accessibility and accuracy of data. Given the high-risk profile of these surgeries, failure to timely detect complications leads to increased mortality and morbidity, which in turn results in increased hospitalization costs and lower quality of life for the affected patients.

For effective cardiac monitoring, surgeons need real time data, 24h continuous monitoring during and post-surgery, and an accurate biosignal marker that can be trusted for immediate detection and assessment of cardiac events. No current technology enables this with low invasiveness and risk.

Cardiaccs (SME) and Osypka (SME) will bring to market a patented solution that involves adding a 3-axis accelerometer to a standard epicardial pace lead, which is routinely used for most cardiac surgical patients, to assess cardiac motion and contractility in real time, both during and after surgery – and up to 7 days. Data from CardiSense will appear on a monitor and an alert function will let surgeons and nurses know as soon as a complication is picked-up on the continuously analysed data.

SAMBAfun brings together 2 SMEs with complementary know-how, IPR and value chain positions. Cardiaccs patented the concept, whereas Osypka has 40 years of experience in developing cardiac pace leads. Osypka dominates the German market and has extensive ties to global distributors. Three leading research hospitals (Oslo, Aarhus and Berlin) will demonstrate the latest advances in this device, provide Key Opinion Leader input and contribute with multi-market, highly credible data for regulatory certification and health economic models to support reimbursement applications in all markets.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

Cardiaccs

Address

Maridalsveien 71b
0458 Oslo

Norway

Activity type

Other

EU Contribution

€ 1 212 221,50

Participants (4)

Sort alphabetically

Sort by EU Contribution

Expand all

OSYPKA AG

Germany

EU Contribution

€ 585 375

OSLO UNIVERSITETSSYKEHUS HF

Norway

EU Contribution

€ 454 903,75

AARHUS UNIVERSITET

Denmark

EU Contribution

€ 487 312,50

DEUTSCHES HERZZENTRUM BERLIN

Germany

EU Contribution

€ 178 500

Project information

Grant agreement ID: 831101

Status

Ongoing project

  • Start date

    1 December 2018

  • End date

    30 November 2021

Funded under:

H2020-EU.3.

H2020-EU.2.1.

  • Overall budget:

    € 3 688 711,25

  • EU contribution

    € 2 918 312,75

Coordinated by:

Cardiaccs

Norway